[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: LNT, SNT, or whatever
>>functions (due to point mutations, non-disjunction, deletions etc) result
>>in tumors. There is more along this line.
--------
> --You are ignoring the factors other than initating events that
affect the development of cancer and may be affected by radiation - like
stimulation of the immune system, stimulated production of repair enzymes
-------------------------------------------------
I am not ignoring these other factors. I am asking for a consistent tumor
theory where we can get molecular data AND epidemiological data into a model
that takes all steps into account. This model may be different for different
histological categories of tumors.
Different tumors arise through different mechanisms & number of underlying
steps. For the retinoblastoma the penetrance is very high and the immune
system doesn't matter. For childhood leukemias the number of genetic factors
to knock out are probably one or two fewer than for many solid tumors.
For chromosomal aberrations (including those scored by the micronucleus
assay), deletions and point mutations, the repair functions have already
been included in the studied endpoint - this is exactly why I mentioned
these lesions.
Furthermore: A tumor seems to develop by a successive series of mutational
events - at least initially. Say 2-3 point mutations or chromosomal events.
These events usually disturb two categories of functions (that sometimes
overlap):
1. The integrity of DNA (repair is an important part of this)
2. Cell cycle regulation.
Once DNA has been damaged in 2-3 of these categories (hundreds of
possibilities) - the genome becomes instable. The emerging tumor cells may
not yet leave their tissue origin and invade other tissues but they now
divide faster and with a higher probability of errors.
Therefore the probability becomes higher (partly because there now are more
of these cells) that these cells eventually obtain DNA damage in genes
relating to the invasive properties. More cells... and they get released
into the blood stream - those that previously were well oxygenated (and
therefore also dividing rapidly) were perhaps killed by the immune
mechanisms - eventually some tumor cells will escape immune system detection
because of mutations relating to the histocompatibility antigen display on
the cell surface (such mechanisms were studied in the early 70:ies by the
use of lectins - the Thesis by Sten Friberg (mouse tumors) is an example).
I would guess that if the immune system takes care of released tumor cells
(not yet fully aggressive in their properties) it is only a matter of time
before they get the final mutations that give them the invasive properties
combined with such that will make them escape the immune functions. The
mechanism here is selection of the worst. The turnover of the tumor cells
can be very high (many trial and errors for more mutations, chromsomal
aberrations etc) with a fast division rate within the first 20 micrometers
or so from a small blood vessel. Those cells that are located further from
the vessel (the order of 50-100 micrometers) will not divide because they
are nutrient and oxygen deficient. The cells that are 100-140 micrometers or
so from the blood vessel are rapidly dying and leaving room for their
neighbors that will take their place and then also die which in turn leaves
more room for cell division in the region near the microvessels.
Therefore there is a high turnover of cells with many chances for the last
and critical metastasis properties to occur. In particular since there
statistically will be a parallel increase of DNA damages disturbing the cell
cycle regulation and DNA repair accuracy & efficiency.
My personal interpretations only,
Bjorn Cedervall bcradsafers@hotmail.com
_________________________________________________________________
Get your FREE download of MSN Explorer at http://explorer.msn.com
************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html